Rapid Micro Biosystems Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.1% | -11.5% | +17.9% | +14.9% | +8.1% | -12.3% | +0.8% | +7.9% | +43.9% | -29.1% | +0.6% | – | |
| – | -16.3% | +9.6% | -4.6% | +2.6% | +3.7% | -6.0% | -21.8% | +4.7% | +108.7% | -34.3% | -10.3% | – | |
| – | – | – | – | – | +57.7% | -58.8% | +381.9% | +16.8% | -114.5% | – | +226.7% | – | |
| – | +6.5% | +15.8% | -2.6% | -3.6% | -5.7% | +6.5% | -10.9% | +9.3% | -8.7% | +4.3% | -0.8% | – | |
| – | -10.8% | +1.6% | +3.4% | -2.4% | -15.0% | +17.9% | +6.8% | -7.2% | -5.4% | +39.4% | -9.1% | – | |
| – | -6.3% | +6.1% | +3.4% | -4.0% | -11.5% | +7.6% | +16.8% | -3.2% | -12.9% | +19.7% | -4.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +0.0% | +3,375.0% | +94.0% | -21.0% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -20.0% | -62.5% | +400.0% | -13.3% | -169.2% | – | +57.1% | -27.3% | +75.0% | -42.9% | +462.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.